adenine has been researched along with cladribine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelrahman, A; Alksnis, E; Borrmann, T; Cristalli, G; Gorzalka, S; Knospe, M; Lambertucci, C; Müller, CE; Schiedel, AC; Volpini, R | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Duley, J; Fabianowska-Majewska, K; Fairbanks, L; Marlewski, M; Simmonds, A; Smoleński, RT; Warzocha, K; Wasiak, TJ | 1 |
| Grippo, P; Hentosh, P | 2 |
| Albertioni, F; Liliemark, J; Lindemalm, S | 1 |
| Bontemps, F; Cardoen, S; Delacauw, A; Van Den Berghe, G; Van Den Neste, E | 1 |
| Bukowska, B; Jóźwiak, Z; Koczmara, M; Marczak, A | 1 |
| Treon, SP | 1 |
| Ekblom, M; Karlsson, MO; Munafo, A; Novakovic, AM; Savic, RM | 1 |
| Bigenzahn, JW; Choi, HS; Felberbauer, F; Gisslinger, H; Gültekin, S; Hoermann, G; Jäger, U; Jeryczynski, G; Kazianka, L; Kenner, L; Korkmaz, B; Kornauth, C; Krall, N; Kralovics, R; Kubicek, S; Lopez de la Fuente, O; Mayerhoefer, ME; Merkel, O; Miura, K; Müllauer, L; Ocko, K; Prager, GW; Prutsch, N; Ringler, A; Sabler, M; Schmolke, AS; Simonitsch-Klupp, I; Snijder, B; Sperr, WR; Staber, PB; Superti-Furga, G; Valent, P; van der Kouwe, E; Vladimer, GI | 1 |
2 trial(s) available for adenine and cladribine
| Article | Year |
|---|---|
Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis.
Topics: Adenine; Administration, Intravenous; Administration, Oral; Adult; Aged; Cladribine; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Models, Biological; Multiple Sclerosis | 2017 |
Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study.
Topics: Adenine; Adult; Aged; Antineoplastic Agents; Area Under Curve; Bone Marrow; Bortezomib; Cladribine; Disease-Free Survival; Female; Hematologic Neoplasms; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Microscopy, Fluorescence; Middle Aged; Odds Ratio; Pilot Projects; Piperidines; Positron Emission Tomography Computed Tomography; Pyrazoles; Pyrimidines; Remission Induction; ROC Curve; Young Adult | 2017 |
9 other study(ies) available for adenine and cladribine
| Article | Year |
|---|---|
Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family.
Topics: Adenine; Animals; Astrocytoma; Cell Line; Cell Line, Tumor; Cerebral Cortex; Humans; Ligands; Protein Binding; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Receptors, Purinergic P1; Structure-Activity Relationship; Tubercidin | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A new mechanism of toxicity of 2-chlorodeoxyadenosine (2CdA).
Topics: Adenine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Adenosylhomocysteinase; Cladribine; Erythrocytes; Humans; Hydrolases; Kinetics; Liver; Purine-Nucleoside Phosphorylase; Substrate Specificity | 1994 |
Template 2-chloro-2'-deoxyadenosine monophosphate inhibits in vitro DNA synthesis.
Topics: Adenine; Bacteriophage M13; Base Sequence; Cladribine; Deoxyribonucleotides; DNA Replication; DNA-Directed DNA Polymerase; DNA, Viral; Humans; Molecular Sequence Data; Templates, Genetic | 1994 |
2-Chloro-2'-deoxyadenosine monophosphate residues in DNA enhance susceptibility to 3'-->5' exonucleases.
Topics: Adenine; Base Sequence; Cladribine; DNA; DNA Nucleotidyltransferases; DNA Polymerase I; DNA Polymerase II; DNA-Directed DNA Polymerase; Escherichia coli; Exodeoxyribonucleases; Molecular Sequence Data; Molecular Weight; Viral Proteins | 1994 |
Stability and analysis of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine and 2-chloroadenine in human blood plasma.
Topics: Adenine; Adenine Nucleotides; Aged; Antineoplastic Agents; Arabinonucleosides; Chromatography, High Pressure Liquid; Cladribine; Clofarabine; Female; Humans; Male; Middle Aged; Reproducibility of Results; Spectrophotometry, Ultraviolet | 1997 |
Metabolism and cytotoxic effects of 2-chloroadenine, the major catabolite of 2-chloro-2'-deoxyadenosine.
Topics: Adenine; Antineoplastic Agents; Cladribine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Nucleotides; Tritium; Tumor Cells, Cultured | 2000 |
The influence of 2-chlorodeoxyadenosine (2-CdA) on the adenine energy charge and glutathione content of human erythrocytes.
Topics: Adenine; Adenosine Monophosphate; Adenosine Triphosphate; Antineoplastic Agents; Cell Death; Cell Shape; Cladribine; Dose-Response Relationship, Drug; Energy Metabolism; Erythrocytes; Glutathione; Humans; In Vitro Techniques; Molecular Structure; Purine Nucleosides; Purine Nucleotides; Suspensions | 2004 |
How I treat Waldenström macroglobulinemia.
Topics: Adenine; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Cladribine; Cyclophosphamide; Everolimus; Gene Expression; Genetic Predisposition to Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin M; Male; Middle Aged; Molecular Targeted Therapy; Myeloid Differentiation Factor 88; Nitrogen Mustard Compounds; Oligopeptides; Piperidines; Plasmapheresis; Pyrazines; Pyrazoles; Pyrimidines; Receptors, CXCR4; Rituximab; Sirolimus; Transplantation, Autologous; Vidarabine; Waldenstrom Macroglobulinemia | 2015 |